Marcks, Nick
Aimo, Alberto
Januzzi, James L. Jr
Vergaro, Giuseppe
Clerico, Aldo
Latini, Roberto
Meessen, Jennifer
Anand, Inder S.
Cohn, Jay N.
Gravning, Jørgen
Ueland, Thor
Bayes-Genis, Antoni
Lupón, Josep
de Boer, Rudolf A.
Yoshihisa, Akiomi
Takeishi, Yasuchika
Egstrup, Michael
Gustafsson, Ida
Gaggin, Hanna K.
Eggers, Kai M.
Huber, Kurt
Tentzeris, Ioannis
Ripoli, Andrea
Passino, Claudio
Sanders-van Wijk, Sandra
Emdin, Michele
Brunner-La Rocca, Hans-Peter http://orcid.org/0000-0002-4356-8566
Article History
Received: 14 December 2020
Accepted: 11 February 2021
First Online: 11 March 2021
Declarations
:
: The author(s) declared no conflicts of interest directly related to this article and the following potential conflicts of interest outside of the submitted work. JLJ: grants and personal fees from Roche, Abbott Diagnostics, Applied Therapeutics, and Siemens, personal fees from Janssen and participation in clinical endpoint committees for Abbvie, Amgen, Bayer, CVRx, and Takeda. ISA reports personal fees from ARCA, AMGEN, Boehringer Ingelheim, Boston Scientific, Novartis, LivaVova, and Zensun. JG reports personal fees from AstraZeneca, Siemens, and Abbott Laboratories. ABG reports personal fees from Novartis, Vifor, AstraZeneca, and Boehringer Ingelheim. RdB reports grants from Abbott, AstraZeneca, Bristol-Myers Squibb, Novartis, NovoNordisk, and Roche to the institute as well as personal fees from Abbott, AstraZeneca, Novartis, and Roche, HKG reports grants from Roche Diagnostics, Jana Care, Ortho Clinical, Novartis, personal fees from Amgen, Eko, Merck, Roche Diagnostics, Radiometer, stoke ownership of Eko, and participation in endpoint committees for Clinical Research for Abbott, Siemens and Beckman Coulter. SSvW reports grants and personal fees from Roche Diagnostics. HPBLR reports grants and personal fees from Novartis, Vifor, Roche Diagnostics, personal fees from Boehringer-Ingelheim and AstraZeneca, and collaboration in international projects with Sananet, Exploris, and Nurogames. All other authors report no conflicts of interest.
: Ethical approval was obtained for all individual studies that form the basis of this meta-analysis and all patients gave informed consent for participation in the according study.
: All authors agreed with the submission of the final version of the manuscript and provided consent for publication.